(UroToday.com) Dr. Karim Fizazi finished off the thematic session of Treatment Sequencing in Metastatic Prostate Cancer with a presentation on the role of PSMA in diagnostics and treatment of metastatic prostate cancer.
PSMA is a transmembrane protein that is often highly expressed by prostate cancer cells and not express by most normal tissues (exception = salivary glands). Expression correlates to advanced disease. It is less expressed by liver metastases.